# Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions

> **NCT01570907** · NA · COMPLETED · sponsor: **Roxane Laboratories** · enrollment: 42 (actual)

## Conditions studied

- Treatment for Bipolar I Disorder

## Interventions

- **DRUG:** Quetiapine Fumarate

## Key facts

- **NCT ID:** NCT01570907
- **Lead sponsor:** Roxane Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01570907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01570907, "Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01570907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*